| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Processa Pharmaceuticals, Inc.
13G
PCSA · 74275C304
|
9.9% |
6/24/2025
Event 6/17/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
Draganfly Inc.
13G
DPRO · 26142Q304
|
9.9% |
6/18/2025
Event 6/11/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
Helius Medical Technologies, Inc.
13G
HSDT · 42328V884
|
5.8% |
6/10/2025
Event 6/4/2025
|
|||
| CVI Investments, Inc. | 5.8% | ||||
| Heights Capital Management, Inc. | 5.8% | ||||
|
Jaguar Health, Inc.
13G/A
Amendment 1
JAGX · 47010C888
|
9.9% |
5/28/2025
Event 5/20/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
Jaguar Health, Inc.
13G
JAGX · 47010C888
|
9.9% |
5/28/2025
Event 5/20/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
Silexion Therapeutics Corp
13G/A
Amendment 1
SLXN · G1281K122
|
4.9% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
RYVYL Inc.
13G/A
Amendment 4
RVYL · 39366L307
|
9.9% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
ReShape Lifesciences Inc.
13G/A
Amendment 1
RSLS · 76090R309
|
5.7% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 5.7% | ||||
| Heights Capital Management, Inc. | 5.7% | ||||
|
Microbot Medical Inc.
13G/A
Amendment 1
MBOT · 59503A204
|
4.9% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Innoviz Technologies Ltd.
13G/A
Amendment 2
INVZ · M5R635108
|
5.5% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 5.5% | ||||
| Heights Capital Management, Inc. | 5.5% | ||||
|
Icon Energy Corp.
13G/A
Amendment 1
ICON · Y4001C206
|
0% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 0% | ||||
| Heights Capital Management, Inc. | 0% | ||||
|
Bionano Genomics, Inc.
13G/A
Amendment 1
BNGO · 09075F404
|
4.9% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Annovis Bio, Inc.
13G/A
Amendment 1
ANVS · 03615A108
|
4.9% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Alset Inc.
13G/A
Amendment 1
AEI · 02115D208
|
0.4% |
5/12/2025
Event 3/31/2025
|
|||
| CVI Investments, Inc. | 0.4% | ||||
| Heights Capital Management, Inc. | 0.4% | ||||
|
Pasithea Therapeutics Corp.
13G
KTTA · 70261F202
|
9.9% |
5/12/2025
Event 5/6/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
BriaCell Therapeutics Corp.
13G
BCTX · 107930208
|
8.6% |
5/1/2025
Event 4/24/2025
|
|||
| CVI Investments, Inc. | 8.6% | ||||
| Heights Capital Management, Inc. | 8.6% | ||||
|
Aptevo Therapeutics Inc.
13G
APVO · 03835L405
|
6.2% |
4/10/2025
Event 4/3/2025
|
|||
| CVI Investments, Inc. | 6.2% | ||||
| Heights Capital Management, Inc. | 6.2% | ||||
|
Innoviz Technologies Ltd.
13G/A
Amendment 1
INVZ · M5R635108
|
9.9% |
3/18/2025
Event 2/10/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
ReShape Lifesciences Inc.
13G
RSLS · 76090R309
|
9.9% |
2/21/2025
Event 2/18/2025
|
|||
| CVI Investments, Inc. | 9.9% | ||||
| Heights Capital Management, Inc. | 9.9% | ||||
|
Innoviz Technologies Ltd.
13G
INVZ · M5R635108
|
7.3% |
2/18/2025
Event 2/10/2025
|
|||
| CVI Investments, Inc. | 7.3% | ||||
| Heights Capital Management, Inc. | 7.3% | ||||
|
Annovis Bio, Inc.
13G
ANVS · 03615A108
|
5.1% |
2/10/2025
Event 2/3/2025
|
|||
| CVI Investments, Inc. | 5.1% | ||||
| Heights Capital Management, Inc. | 5.1% | ||||
|
Theriva Biologics, Inc.
13G/A
Amendment 1
TOVX · 87164U508
|
4.9% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Reviva Pharmaceuticals Holdings, Inc.
13G/A
Amendment 1
RVPH · 76152G100
|
4.9% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Rigetti Computing, Inc.
13G/A
Amendment 1
RGTI · 76655K103
|
0% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 0% | ||||
| Heights Capital Management, Inc. | 0% | ||||
|
PSQ Holdings, Inc.
13G/A
Amendment 1
PSQH · 693691107
|
3.3% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 3.3% | ||||
| Heights Capital Management, Inc. | 3.3% | ||||
|
PSQ Holdings, Inc.
13G/A
Amendment 1
PSQH · 693691107
|
3.3% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 3.3% | ||||
| Heights Capital Management, Inc. | 3.3% | ||||
|
Phio Pharmaceuticals Corp.
13G/A
Amendment 1
PHIO · 71880W501
|
4.9% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Snow Lake Resources Ltd.
13G/A
Amendment 1
LITM · 83336J208
|
0% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 0% | ||||
| Heights Capital Management, Inc. | 0% | ||||
|
Gaxos.ai Inc.
13G/A
Amendment 1
GXAI · 62911P300
|
4.9% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
Candel Therapeutics, Inc.
13G/A
Amendment 1
CADL · 137404109
|
0% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 0% | ||||
| Heights Capital Management, Inc. | 0% | ||||
|
Atossa Therapeutics, Inc.
13G/A
Amendment 2
ATOS · 04962H506
|
4.3% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 4.3% | ||||
| Heights Capital Management, Inc. | 4.3% | ||||
|
Autonomix Medical, Inc.
13G/A
Amendment 1
AMIX · 05330T205
|
4.9% |
2/7/2025
Event 12/31/2024
|
|||
| CVI Investments, Inc. | 4.9% | ||||
| Heights Capital Management, Inc. | 4.9% | ||||
|
FG Merger II Corp.
13G
FGMCU · 30334J201
|
7.7% |
2/5/2025
Event 1/29/2025
|
|||
| CVI Investments, Inc. | 7.7% | ||||
| Heights Capital Management, Inc. | 7.7% | ||||
|
Icon Energy Corp.
13G
ICON · Y4001C107
|
6.9% |
1/30/2025
Event 1/23/2025
|
|||
| CVI Investments, Inc. | 6.9% | ||||
| Heights Capital Management, Inc. | 6.9% | ||||
|
Silexion Therapeutics Corp
13G
SLXN · G1281K122
|
8.5% |
1/23/2025
Event 1/15/2025
|
|||
| CVI Investments, Inc. | 8.5% | ||||
| Heights Capital Management, Inc. | 8.5% | ||||
|
Microbot Medical Inc.
13G
MBOT · 59503A204
|
6.1% |
1/13/2025
Event 1/6/2025
|
|||
| CVI Investments, Inc. | 6.1% | ||||
| Heights Capital Management, Inc. | 6.1% | ||||
|
Bionano Genomics, Inc.
13G
BNGO · 09075F305
|
7.7% |
1/13/2025
Event 1/3/2025
|
|||
| CVI Investments, Inc. | 7.7% | ||||
| Heights Capital Management, Inc. | 7.7% | ||||
|
Alset Inc.
13G
AEI · 02115D208
|
7.0% |
1/10/2025
Event 1/2/2025
|
|||
| CVI Investments, Inc. | 7.0% | ||||
| Heights Capital Management, Inc. | 7.0% | ||||
|
Snow Lake Resources Ltd.
13G
LITM · 83336J208
|
6.5% |
1/7/2025
Event 12/28/2024
|
|||
| CVI Investments, Inc. | 6.5% | ||||
| Heights Capital Management, Inc. | 6.5% | ||||
|
Phio Pharmaceuticals Corp.
13G
PHIO · 71880W501
|
7.3% |
12/26/2024
Event 12/19/2024
|
|||
| CVI Investments, Inc. | 7.3% | ||||
| Heights Capital Management, Inc. | 7.3% | ||||
|
Gaxos.ai Inc.
13G
GXAI · 62911P300
|
9.1% |
12/26/2024
Event 12/18/2024
|
|||
| CVI Investments, Inc. | 9.1% | ||||
| Heights Capital Management, Inc. | 9.1% | ||||
|
Reviva Pharmaceuticals Holdings, Inc.
13G
RVPH · 76152G100
|
7.2% |
12/23/2024
Event 12/16/2024
|
|||
| CVI Investments, Inc. | 7.2% | ||||
| Heights Capital Management, Inc. | 7.2% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.